+49 711 500 989 80
deen

First patient-derived cells to study leptomeningeal disease



First patient-derived cells to study leptomeningeal disease

A team of researchers has been able to add an important resource to study leptomeningeal disease by successfully growing and culturing circulating tumor cells derived from the cerebrospinal fluid of patients with melanoma leptomeningeal disease.

Materials provided by H. Lee Moffitt Cancer Center & Research Institute. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

27th September 2022

Rhombic lip implicated in origins of high-risk medulloblastoma

Read more
27th September 2022

How prostate cancer may begin

Read more
27th September 2022

Diets rich in refined fiber may increase liver cancer risk in some individuals

Read more